The Global Pathogen Center for Pathogen Research and Human Health to broaden understanding of emerging pathogens – ranging from Zika virus to SARS-CoV-2 (which causes COVID-19) – and to expedite critically needed treatments and vaccines.
Juniper Pharma Services (JPS), a Contract Development and Manufacturing Organisation (CDMO) specialising in the development of challenging small molecules, has announced a significant expansion to its UK-based drug development and clinical trial manufacturing facilities.
China manufacturing facility to support the growing needs of the Asia-Pacific pharmaceutical and medical device markets that are supported with products developed by Tekni-Plex’s Colorite, Natvar and Action Technology business units.
Batavia Biosciences announces the expansion of its viral vector process development facilities in the USA and its GMP clean room facilities in the Netherlands to accommodate the increasing market demand.
